IMMUNO-COV™ – The Test for Antibodies that Block SARS-CoV-2 Infection Read More

February 11-12, 2019

Bio CEO and Investor Conference

Kah-Whye Peng, Ph.D., Vyriad Chief Technical Officer
Presentation: “Oncolytic Viruses for IV Cancer Therapy”

Visit event site

Media Inquiries

For inquiries, please contact mediarelations@vyriad.com